The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
- PMID: 18795920
- DOI: 10.1111/j.1365-2133.2008.08832.x
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
Abstract
Background: The Dermatology Life Quality Index (DLQI) is one of the most widely used dermatology-specific quality of life instruments. Over the last 5 years there has been great interest in its use.
Objectives: To collect and present all information regarding the technical properties and the clinical use of the DLQI from the date it was published to the end of 2007 for use as a single source of reference.
Methods: A detailed literature search was conducted using electronic reference databases and the DLQI library in the Department of Dermatology, Cardiff University. All publications mentioning any aspect of the DLQI, from the time of its development to the end of 2007, were identified and the data concerning the DLQI in terms of its psychometric analysis, and use in clinical trials, epidemiological studies and health services research, were extracted and tabulated with all the relevant references.
Results: In total, 272 full articles which have included the DLQI were reviewed. Studies described in these articles were divided into five main categories: psychometric studies, descriptive/epidemiological studies, drug (topical and systemic) trials, clinical practice research, and therapeutic interventions. The DLQI has been used in 33 different skin conditions in 32 countries and is available in 55 languages. Psychometric aspects of the DLQI such as validity, reliability, responsiveness to change, factor structure, and minimal important difference were described in 115 studies. The DLQI has been used in 33 studies assessing the effectiveness of 14 different types of therapeutic interventions and in 37 studies evaluating nine types of clinical practice research. Sixty studies have used it alone or in parallel with other instruments as an outcome measure in clinical trials of 18 systemic drugs while 22 studies have used it in 14 different topical drug trials. The DLQI has also been used in 27 multinational studies.
Conclusions: During the last 14 years there has been a gradual increase in the international use of the DLQI. The brevity and simplicity of use of the DLQI has resulted in its popularity both in clinical practice and in research. However, there are various issues in particular regarding its unidimensionality, differential item functioning, and minimal clinically important difference, which require further research. This article should facilitate the work of potential users of the DLQI by providing a readily available source of references for different aspects of the DLQI.
Similar articles
-
Infants' Dermatitis Quality of Life Index: a decade of experience of validation and clinical application.Br J Dermatol. 2013 Oct;169(4):760-8. doi: 10.1111/bjd.12563. Br J Dermatol. 2013. PMID: 23909890 Review.
-
Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012.Br J Dermatol. 2013 Oct;169(4):734-59. doi: 10.1111/bjd.12437. Br J Dermatol. 2013. PMID: 23679682 Review.
-
The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease.Br J Dermatol. 2007 Mar;156(3):528-38. doi: 10.1111/j.1365-2133.2006.07617.x. Br J Dermatol. 2007. PMID: 17300244
-
[Assessment on the reliability and validity of the Dermatology Life Quality Index in Chinese version].Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Sep;25(9):791-3. Zhonghua Liu Xing Bing Xue Za Zhi. 2004. PMID: 15555362 Chinese.
-
Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life.Ann Allergy Asthma Immunol. 2004 Aug;93(2):142-6. doi: 10.1016/S1081-1206(10)61466-4. Ann Allergy Asthma Immunol. 2004. PMID: 15328673 Clinical Trial.
Cited by
-
Health-related quality of life in patients with generalized pustular psoriasis - a Swedish register study.Ann Med. 2024 Dec;56(1):2341252. doi: 10.1080/07853890.2024.2341252. Epub 2024 May 13. Ann Med. 2024. PMID: 38738413 Free PMC article.
-
Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60.Dermatol Ther (Heidelb). 2024 Apr;14(4):1007-1018. doi: 10.1007/s13555-024-01147-7. Epub 2024 Apr 22. Dermatol Ther (Heidelb). 2024. PMID: 38647975 Free PMC article.
-
Efficacy and safety of topical rosuvastatin & melatonin vs. placebo in patients with mild to moderate plaque psoriasis: A preliminary randomized double-blinded clinical trial.Skin Res Technol. 2024 Apr;30(4):e13689. doi: 10.1111/srt.13689. Skin Res Technol. 2024. PMID: 38563131 Free PMC article. Clinical Trial.
-
The Burden of Pediatric Atopic Dermatitis: Quality of Life of Patients and Their Families.J Clin Med. 2024 Mar 15;13(6):1700. doi: 10.3390/jcm13061700. J Clin Med. 2024. PMID: 38541925 Free PMC article.
-
Effects of Different Therapeutic Approaches on Redox Balance in Psoriatic Patients.Biomedicines. 2024 Mar 6;12(3):587. doi: 10.3390/biomedicines12030587. Biomedicines. 2024. PMID: 38540199 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical